Q9Z0E8
Gene name |
Slc22a5 (Octn2) |
Protein name |
Solute carrier family 22 member 5 |
Names |
High-affinity sodium-dependent carnitine cotransporter, Organic cation/carnitine transporter 2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:20520 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9Z0E8
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9Z0E8-F1 | Predicted | AlphaFoldDB |
37 variants for Q9Z0E8
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs8239667 | 16 | P>T | No | EVA | |
| rs247598141 | 55 | T>S | No | EVA | |
| rs8264672 | 75 | R>P | No | EVA | |
| rs8264673 | 76 | Q>E | No | EVA | |
| rs8264678 | 112 | S>N | No | EVA | |
| rs8264679 | 123 | V>I | No | EVA | |
| rs3389151442 | 245 | V>M | No | EVA | |
| rs3389154206 | 259 | L>Q | No | EVA | |
| rs3389155446 | 267 | G>V | No | EVA | |
| rs3389094745 | 269 | L>I | No | EVA | |
| rs3389120087 | 286 | S>P | No | EVA | |
| rs3389167307 | 289 | R>L | No | EVA | |
| rs8264633 | 321 | L>F | No | EVA | |
| rs8264632 | 322 | N>S | No | EVA | |
| rs8264629 | 328 | L>S | No | EVA | |
| rs3389157638 | 329 | H>L | No | EVA | |
| rs8264628 | 335 | I>V | No | EVA | |
| rs3389158916 | 340 | I>F | No | EVA | |
| rs8264625 | 342 | V>I | No | EVA | |
| rs8264624 | 343 | I>L | No | EVA | |
| rs3389127263 | 343 | I>T | No | EVA | |
| rs3389149470 | 344 | T>I | No | EVA | |
| rs3389131554 | 347 | S>Y | No | EVA | |
| 352 | L>R | JVS [UniProt] | No | ||
| rs3389154190 | 366 | P>S | No | EVA | |
| rs3389158855 | 368 | L>F | No | EVA | |
| rs3389131594 | 375 | N>Y | No | EVA | |
| rs3389094786 | 410 | G>A | No | EVA | |
| rs3389155396 | 421 | P>S | No | EVA | |
| rs3389156666 | 425 | F>L | No | EVA | |
| rs3389154207 | 462 | G>VSDG* | No | EVA | |
| rs3389131569 | 471 | R>C | No | EVA | |
| rs3389155424 | 490 | L>Q | No | EVA | |
| rs3389094809 | 497 | S>N | No | EVA | |
| rs3389167175 | 507 | L>F | No | EVA | |
| rs3389094797 | 508 | F>L | No | EVA | |
| rs3389167353 | 512 | S>C | No | EVA |
1 associated diseases with Q9Z0E8
Without disease ID
Functions
8 GO annotations of cellular component
| Name | Definition |
|---|---|
| apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
| basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
| brush border membrane | The portion of the plasma membrane surrounding the brush border. |
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
6 GO annotations of molecular function
| Name | Definition |
|---|---|
| (R)-carnitine transmembrane transporter activity | Enables the transfer of (R)-carnitine from one side of a membrane to the other. |
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| carnitine transmembrane transporter activity | Enables the transfer of carnitine across a membrane. Carnitine is a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane. |
| PDZ domain binding | Binding to a PDZ domain of a protein, a domain found in diverse signaling proteins. |
| quaternary ammonium group transmembrane transporter activity | Enables the transfer of quaternary ammonium groups from one side of a membrane to the other. Quaternary ammonium groups are any compound that can be regarded as derived from ammonium hydroxide or an ammonium salt by replacement of all four hydrogen atoms of the NH4+ ion by organic groups. |
| symporter activity | Enables the active transport of a solute across a membrane by a mechanism whereby two or more species are transported together in the same direction in a tightly coupled process not directly linked to a form of energy other than chemiosmotic energy. |
14 GO annotations of biological process
| Name | Definition |
|---|---|
| (R)-carnitine transmembrane transport | The process in which (R)-carnitine is transported across a membrane. |
| adult heart development | The process whose specific outcome is the progression of the adult heart over time, from its formation to the mature structure. |
| carnitine metabolic process | The chemical reactions and pathways involving carnitine (hydroxy-trimethyl aminobutyric acid), a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane. |
| carnitine transport | The directed movement of carnitine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Carnitine is a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane. |
| establishment of localization in cell | Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation. |
| locomotory behavior | The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. |
| mitochondrion organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. |
| positive regulation of intestinal epithelial structure maintenance | Any process the increases the rate, frequency or extent of intestinal epithelial structure maintenance, a tissue homeostatic process required for the maintenance of the structure of the intestinal epithelium. |
| quaternary ammonium group transport | The directed movement into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore of quaternary ammonium compounds, any compound that can be regarded as derived from ammonium hydroxide or an ammonium salt by replacement of all four hydrogen atoms of the NH4+ ion by organic groups. |
| reproductive structure development | The reproductive developmental process whose specific outcome is the progression of somatic structures that will be used in the process of creating new individuals from one or more parents, from their formation to the mature structures. |
| response to symbiotic bacterium | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a symbiotic bacterium, a bacterium living in close physical association with another organism. |
| sodium ion transport | The directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| sodium-dependent organic cation transport | The directed, sodium-dependent, movement of organic cations into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| transport across blood-brain barrier | The directed movement of substances (e.g. macromolecules, small molecules, ions) through the blood-brain barrier. |
18 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q17QN9 | SLC22A16 | Solute carrier family 22 member 16 | Bos taurus (Bovine) | PR |
| Q1JP63 | SVOP | Synaptic vesicle 2-related protein | Bos taurus (Bovine) | PR |
| Q9H015 | SLC22A4 | Solute carrier family 22 member 4 | Homo sapiens (Human) | PR |
| Q7L1I2 | SV2B | Synaptic vesicle glycoprotein 2B | Homo sapiens (Human) | PR |
| Q496J9 | SV2C | Synaptic vesicle glycoprotein 2C | Homo sapiens (Human) | PR |
| Q8N4V2 | SVOP | Synaptic vesicle 2-related protein | Homo sapiens (Human) | PR |
| A6NKX4 | SLC22A31 | Putative solute carrier family 22 member 31 | Homo sapiens (Human) | PR |
| Q69ZS6 | Sv2c | Synaptic vesicle glycoprotein 2C | Mus musculus (Mouse) | PR |
| Q8BFT9 | Svop | Synaptic vesicle 2-related protein | Mus musculus (Mouse) | PR |
| Q9Z306 | Slc22a4 | Solute carrier family 22 member 4 | Mus musculus (Mouse) | PR |
| Q9D9E0 | Slc22a17 | Solute carrier family 22 member 17 | Mus musculus (Mouse) | PR |
| Q497L8 | Slc22a16 | Solute carrier family 22 member 16 | Mus musculus (Mouse) | PR |
| Q6PDF3 | Svopl | Putative transporter SVOPL | Mus musculus (Mouse) | PR |
| Q70BM6 | SLC22A8 | Organic anion transporter 3 | Sus scrofa (Pig) | PR |
| Q9Z2I7 | Svop | Synaptic vesicle 2-related protein | Rattus norvegicus (Rat) | PR |
| Q9Z2I6 | Sv2c | Synaptic vesicle glycoprotein 2C | Rattus norvegicus (Rat) | PR |
| Q9R141 | Slc22a4 | Solute carrier family 22 member 4 | Rattus norvegicus (Rat) | PR |
| Q7Z118 | B0361.11 | Putative transporter B0361.11 | Caenorhabditis elegans | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MRDYDEVTAF | LGEWGPFQRL | IFFLLSASII | PNGFNGMSIV | FLAGTPEHRC | LVPHTVNLSS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| AWRNHSIPLE | TKDGRQVPQK | CRRYRLATIA | NFSELGLEPG | RDVDLEQLEQ | ESCLDGWEYD |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KDVFLSTIVT | EWDLVCKDDW | KAPLTTSLFF | VGVLMGSFIS | GQLSDRFGRK | NVLFLTMGMQ |
| 190 | 200 | 210 | 220 | 230 | 240 |
| TGFSFLQVFS | VNFEMFTVLF | VLVGMGQISN | YVAAFVLGTE | ILSKSIRIIF | ATLGVCIFYA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| FGFMVLPLFA | YFIRDWRMLL | LALTVPGVLC | GALWWFIPES | PRWLISQGRI | KEAEVIIRKA |
| 310 | 320 | 330 | 340 | 350 | 360 |
| AKINGIVAPS | TIFDPSELQD | LNSTKPQLHH | IYDLIRTRNI | RVITIMSIIL | WLTISVGYFG |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LSLDTPNLHG | DIYVNCFLLA | AVEVPAYVLA | WLLLQYLPRR | YSISAALFLG | GSVLLFMQLV |
| 430 | 440 | 450 | 460 | 470 | 480 |
| PSELFYLSTA | LVMVGKFGIT | SAYSMVYVYT | AELYPTVVRN | MGVGVSSTAS | RLGSILSPYF |
| 490 | 500 | 510 | 520 | 530 | 540 |
| VYLGAYDRFL | PYILMGSLTI | LTAILTLFFP | ESFGVPLPDT | IDQMLRVKGI | KQWQIQSQTR |
| 550 | |||||
| MQKDGEESPT | VLKSTAF |